Sebaceous adenitis of the vulva responsive to antiandrogens.

BMJ Case Rep

Pathology North, Newcastle, New South Wales, Australia.

Published: June 2018

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5990069PMC
http://dx.doi.org/10.1136/bcr-2018-225655DOI Listing

Publication Analysis

Top Keywords

sebaceous adenitis
4
adenitis vulva
4
vulva responsive
4
responsive antiandrogens
4
sebaceous
1
vulva
1
responsive
1
antiandrogens
1

Similar Publications

Correlation between meibomian gland dysfunction and sebaceous adenitis in dogs.

Vet Dermatol

December 2024

Small Animal Department, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium.

Background: Sebaceous adenitis (SA) is an immune-mediated disease targeting the sebaceous glands. Meibomian gland dysfunction is a disease affecting meibomian glands with inflammatory features. Sebaceous and meibomian glands share anatomical, physiological and embryological similarities.

View Article and Find Full Text PDF

Background: Diascopy is a point-of-care diagnostic test used to differentiate skin erythema due to vascular dilation from haemorrhage. In the veterinary literature, only a handful of diseases have been described to be associated with a negative (nonblanching) diascopy result, and histological investigation of haemorrhage has been inconsistent.

Objectives: Retrospective study to undertake a histopathological investigation of canine, nonblanching erythematous dermatoses for the presence or absence of haemorrhage and vascular changes.

View Article and Find Full Text PDF

Finding an effective and well-tolerated treatment for canine idiopathic sebaceous adenitis (ISA) can be challenging. This case report describes an 8-year-old male Rottweiler with ISA successfully treated with a combination of oclacitinib and low doses of prednisolone.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!